Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cassader

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Journal of Endocrinological Investigation|December 24, 2005
C-reactive protein and tumor necrosis factor-alpha in gestational hyperglycemiaS Bo, A Signorile, G Menato, et al.
Current Medicinal Chemistry|January 10, 2013
Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trialS Bo, G Ciccone, A Castiglione, et al.
Diabetes & Metabolism|May 19, 2018
Incidence of diabetes mellitus, cardiovascular outcomes and mortality after a 12-month lifestyle intervention: A 9-year follow-upV Ponzo, L Gentile, R Gambino, et al.
Diabetologia|March 5, 2005
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanismsE Bugianesi, A Gastaldelli, E Vanni, et al.
European Journal of Clinical Investigation|April 9, 2005
Does C-reactive protein identify a subclinical metabolic disease in healthy subjects?S Bo, R Gambino, B Uberti, et al.
Diabetes & Metabolism|May 15, 2003
Obesity or diabetes: what is worse for the mother and for the baby?S Bo, G Menato, A Signorile, et al.
Pharmacological Research|August 14, 2016
Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trialS Bo, V Ponzo, G Ciccone, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 17, 2008
Plasma visfatin concentrations after a lifestyle intervention were directly associated with inflammatory markersS Bo, G Ciccone, I Baldi, et al.
International Journal of Obesity (2005)|February 3, 2011
Contributors to the obesity and hyperglycemia epidemics. A prospective study in a population-based cohortS Bo, G Ciccone, M Durazzo, et al.
Diabetes|April 6, 2001
Autoantibody response to CD38 in Caucasian patients with type 1 and type 2 diabetes: immunological and genetic characterizationR Mallone, E Ortolan, G Baj, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Journal of Endocrinological Investigation|December 24, 2005
C-reactive protein and tumor necrosis factor-alpha in gestational hyperglycemiaS Bo, A Signorile, G Menato, et al.
Current Medicinal Chemistry|January 10, 2013
Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trialS Bo, G Ciccone, A Castiglione, et al.
Diabetes & Metabolism|May 19, 2018
Incidence of diabetes mellitus, cardiovascular outcomes and mortality after a 12-month lifestyle intervention: A 9-year follow-upV Ponzo, L Gentile, R Gambino, et al.
Diabetologia|March 5, 2005
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanismsE Bugianesi, A Gastaldelli, E Vanni, et al.
European Journal of Clinical Investigation|April 9, 2005
Does C-reactive protein identify a subclinical metabolic disease in healthy subjects?S Bo, R Gambino, B Uberti, et al.
Diabetes & Metabolism|May 15, 2003
Obesity or diabetes: what is worse for the mother and for the baby?S Bo, G Menato, A Signorile, et al.
Pharmacological Research|August 14, 2016
Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trialS Bo, V Ponzo, G Ciccone, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 17, 2008
Plasma visfatin concentrations after a lifestyle intervention were directly associated with inflammatory markersS Bo, G Ciccone, I Baldi, et al.
International Journal of Obesity (2005)|February 3, 2011
Contributors to the obesity and hyperglycemia epidemics. A prospective study in a population-based cohortS Bo, G Ciccone, M Durazzo, et al.
Diabetes|April 6, 2001
Autoantibody response to CD38 in Caucasian patients with type 1 and type 2 diabetes: immunological and genetic characterizationR Mallone, E Ortolan, G Baj, et al.
Pageof 10